Aquinox Pharmaceuticals
company
About
Aquinox Pharmaceuticals develops and commercializes small molecule therapeutics for the treatment of cancer and inflammatory diseases.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $14.50M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2004
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$32.50M
Aquinox Pharmaceuticals has raised a total of
$32.50M
in funding over 2 rounds. Their latest funding was raised on
Apr 3, 2013 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 3, 2013 | Series C | $18M | 1 | — | — | Detail |
| Jun 12, 2007 | Series A | $14.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Aquinox Pharmaceuticals is funded by 2 investors.
Inbio Ventures
and BC Advantage Funds
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Inbio Ventures
|
— | Series C |
BC Advantage Funds
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
